Outcomes after stem cell transplant in elderly patients with acute myeloid leukemia have improved since 2000
March 22 - Among patients over 65 who received an allogeneic hematopoietic stem cell transplant (allo-HCT) for the treatment of acute myeloid leukemia (AML) between 2000 and 2021, leukemia-free and overall survival improved significantly over time.